nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—Orlistat—obesity	0.366	1	CbGbCtD
Glycerol Phenylbutyrate—PNLIP—obesity	0.365	1	CbGaD
Glycerol Phenylbutyrate—Alverine—Benzphetamine—obesity	0.166	1	CrCrCtD
Glycerol Phenylbutyrate—PNLIP—islet of Langerhans—obesity	0.00365	0.182	CbGeAlD
Glycerol Phenylbutyrate—Hyperammonaemia—Topiramate—obesity	0.00348	0.0966	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—respiratory system—obesity	0.00344	0.172	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—cardiovascular system—obesity	0.00264	0.132	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—pituitary gland—obesity	0.00234	0.117	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—adipose tissue—obesity	0.00233	0.116	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—digestive system—obesity	0.00219	0.109	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—endocrine gland—obesity	0.00181	0.0904	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—liver—obesity	0.00163	0.0815	CbGeAlD
Glycerol Phenylbutyrate—Abdominal pain upper—Phendimetrazine—obesity	0.00108	0.0301	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Diethylpropion—obesity	0.000698	0.0194	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Methamphetamine—obesity	0.000583	0.0162	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Methamphetamine—obesity	0.000572	0.0159	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Benzphetamine—obesity	0.000562	0.0156	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Benzphetamine—obesity	0.000555	0.0154	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Benzphetamine—obesity	0.000552	0.0153	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Phendimetrazine—obesity	0.000506	0.0141	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Cimetidine—obesity	0.000476	0.0132	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Phendimetrazine—obesity	0.00046	0.0128	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Methamphetamine—obesity	0.000453	0.0126	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Methamphetamine—obesity	0.000438	0.0122	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Benzphetamine—obesity	0.000437	0.0121	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Benzphetamine—obesity	0.000423	0.0117	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Phentermine—obesity	0.000419	0.0116	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Methamphetamine—obesity	0.000415	0.0115	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Phentermine—obesity	0.000411	0.0114	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Phentermine—obesity	0.00041	0.0114	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Orlistat—obesity	0.000404	0.0112	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Benzphetamine—obesity	0.0004	0.0111	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Phendimetrazine—obesity	0.000398	0.0111	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Phendimetrazine—obesity	0.000385	0.0107	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Benzphetamine—obesity	0.00038	0.0105	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Phentermine—obesity	0.000376	0.0105	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Orlistat—obesity	0.000367	0.0102	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Phendimetrazine—obesity	0.000365	0.0101	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Diethylpropion—obesity	0.000365	0.0101	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Diethylpropion—obesity	0.000358	0.00993	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Phendimetrazine—obesity	0.000346	0.00961	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Phentermine—obesity	0.000342	0.00949	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Bupropion—obesity	0.000341	0.00948	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Cimetidine—obesity	0.00034	0.00944	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Phenylpropanolamine—obesity	0.000329	0.00914	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Phentermine—obesity	0.000326	0.00905	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Phenylpropanolamine—obesity	0.000316	0.00879	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Phentermine—obesity	0.000315	0.00875	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Phenylpropanolamine—obesity	0.000314	0.00872	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Phenylpropanolamine—obesity	0.000313	0.00871	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Bupropion—obesity	0.000309	0.0086	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Phentermine—obesity	0.000303	0.00841	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Phentermine—obesity	0.0003	0.00834	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Phentermine—obesity	0.0003	0.00833	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Phentermine—obesity	0.000298	0.00829	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Phenylpropanolamine—obesity	0.000295	0.00821	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Diethylpropion—obesity	0.000283	0.00787	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Phentermine—obesity	0.000283	0.00786	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Cimetidine—obesity	0.000283	0.00786	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Diethylpropion—obesity	0.000274	0.00761	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Cimetidine—obesity	0.00027	0.00749	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Orlistat—obesity	0.000267	0.00741	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Diethylpropion—obesity	0.000263	0.00732	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Orlistat—obesity	0.000263	0.0073	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Diethylpropion—obesity	0.000261	0.00726	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Diethylpropion—obesity	0.000261	0.00725	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Cimetidine—obesity	0.000261	0.00724	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Diethylpropion—obesity	0.000259	0.00721	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Sibutramine—obesity	0.000258	0.00717	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Sibutramine—obesity	0.000254	0.00706	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Cimetidine—obesity	0.000251	0.00696	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Cimetidine—obesity	0.000248	0.0069	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Cimetidine—obesity	0.000248	0.0069	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Cimetidine—obesity	0.000247	0.00686	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Diethylpropion—obesity	0.000246	0.00684	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Cimetidine—obesity	0.000234	0.0065	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Bupropion—obesity	0.000225	0.00625	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Bupropion—obesity	0.000222	0.00616	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Topiramate—obesity	0.000217	0.00604	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Orlistat—obesity	0.000213	0.00593	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Topiramate—obesity	0.000197	0.00548	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Orlistat—obesity	0.000192	0.00532	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Orlistat—obesity	0.000189	0.00525	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Orlistat—obesity	0.000188	0.00522	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Orlistat—obesity	0.000188	0.00521	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Sibutramine—obesity	0.000185	0.00515	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Sibutramine—obesity	0.000183	0.00509	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Sibutramine—obesity	0.000182	0.00505	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Bupropion—obesity	0.00018	0.005	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Orlistat—obesity	0.000178	0.00494	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Sibutramine—obesity	0.000172	0.00478	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Orlistat—obesity	0.000172	0.00478	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Sibutramine—obesity	0.000166	0.00462	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Bupropion—obesity	0.000162	0.00449	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Bupropion—obesity	0.00016	0.00443	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Bupropion—obesity	0.000158	0.0044	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Bupropion—obesity	0.000158	0.0044	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Orlistat—obesity	0.000156	0.00434	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Sibutramine—obesity	0.000151	0.0042	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Bupropion—obesity	0.00015	0.00417	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Orlistat—obesity	0.000149	0.00414	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Bupropion—obesity	0.000145	0.00403	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Sibutramine—obesity	0.000144	0.004	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Orlistat—obesity	0.000144	0.004	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Topiramate—obesity	0.000143	0.00398	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Topiramate—obesity	0.000141	0.00392	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Sibutramine—obesity	0.000139	0.00387	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Orlistat—obesity	0.000138	0.00384	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Orlistat—obesity	0.000137	0.00381	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Orlistat—obesity	0.000137	0.00381	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Orlistat—obesity	0.000136	0.00379	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Sibutramine—obesity	0.000134	0.00372	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Sibutramine—obesity	0.000133	0.00369	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Sibutramine—obesity	0.000133	0.00369	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Sibutramine—obesity	0.000132	0.00366	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Bupropion—obesity	0.000132	0.00366	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Orlistat—obesity	0.000129	0.00359	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Bupropion—obesity	0.000126	0.00349	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Sibutramine—obesity	0.000125	0.00347	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Bupropion—obesity	0.000121	0.00337	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Bupropion—obesity	0.000117	0.00324	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Bupropion—obesity	0.000116	0.00322	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Bupropion—obesity	0.000116	0.00321	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Bupropion—obesity	0.000115	0.0032	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Topiramate—obesity	0.000115	0.00319	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Bupropion—obesity	0.000109	0.00303	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Topiramate—obesity	0.000103	0.00286	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Topiramate—obesity	0.000102	0.00282	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Topiramate—obesity	0.000101	0.00281	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Topiramate—obesity	0.000101	0.0028	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Topiramate—obesity	9.56e-05	0.00266	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Topiramate—obesity	9.24e-05	0.00257	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Topiramate—obesity	8.39e-05	0.00233	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Topiramate—obesity	8e-05	0.00222	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRLHR—obesity	7.86e-05	0.00165	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GH1—obesity	7.86e-05	0.00165	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SH2B1—obesity	7.86e-05	0.00165	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPARD—obesity	7.82e-05	0.00164	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ACP5—obesity	7.78e-05	0.00163	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Topiramate—obesity	7.73e-05	0.00215	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC27A1—obesity	7.66e-05	0.00161	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—G6PD—obesity	7.58e-05	0.00159	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—FABP4—obesity	7.51e-05	0.00158	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GLUL—obesity	7.51e-05	0.00158	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HK1—obesity	7.49e-05	0.00157	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Topiramate—obesity	7.44e-05	0.00207	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APLN—obesity	7.39e-05	0.00155	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PYY—obesity	7.39e-05	0.00155	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Topiramate—obesity	7.37e-05	0.00205	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Topiramate—obesity	7.37e-05	0.00205	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Topiramate—obesity	7.33e-05	0.00204	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	7.24e-05	0.00152	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HSD11B1—obesity	7.12e-05	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ECHS1—obesity	7.12e-05	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—UCP3—obesity	7.12e-05	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—UCP2—obesity	7.12e-05	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ADH1B—obesity	7.01e-05	0.00147	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Topiramate—obesity	6.95e-05	0.00193	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOB—obesity	6.91e-05	0.00145	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ACSL1—obesity	6.9e-05	0.00145	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPARGC1B—obesity	6.9e-05	0.00145	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GPAM—obesity	6.9e-05	0.00145	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SDC3—obesity	6.84e-05	0.00144	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PCK1—obesity	6.7e-05	0.00141	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HADH—obesity	6.7e-05	0.00141	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—FADS1—obesity	6.7e-05	0.00141	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NMU—obesity	6.68e-05	0.0014	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PMCH—obesity	6.68e-05	0.0014	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HCRT—obesity	6.68e-05	0.0014	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NPY5R—obesity	6.68e-05	0.0014	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—LPL—obesity	6.59e-05	0.00139	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ACP5—obesity	6.52e-05	0.00137	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—RBP4—obesity	6.45e-05	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—GPX1—obesity	6.43e-05	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MC4R—obesity	6.41e-05	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MC3R—obesity	6.41e-05	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NPY2R—obesity	6.41e-05	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NPY1R—obesity	6.41e-05	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—G6PD—obesity	6.35e-05	0.00133	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PPY—obesity	6.28e-05	0.00132	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HK1—obesity	6.27e-05	0.00132	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SREBF2—obesity	6.27e-05	0.00132	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CD36—obesity	6.27e-05	0.00132	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRKCH—obesity	6.17e-05	0.0013	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HDAC8—obesity	6.17e-05	0.0013	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GIP—obesity	6.17e-05	0.0013	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CST3—obesity	6.11e-05	0.00128	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PRKAR2B—obesity	6.11e-05	0.00128	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—DCN—obesity	6.06e-05	0.00127	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LPA—obesity	6.06e-05	0.00127	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LPIN1—obesity	5.93e-05	0.00125	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NCF2—obesity	5.9e-05	0.00124	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LEPR—obesity	5.86e-05	0.00123	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PPARA—obesity	5.82e-05	0.00122	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOA5—obesity	5.81e-05	0.00122	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NAMPT—obesity	5.78e-05	0.00121	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—GCK—obesity	5.75e-05	0.00121	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IAPP—obesity	5.71e-05	0.0012	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOC3—obesity	5.71e-05	0.0012	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—AGT—obesity	5.64e-05	0.00119	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC22A1—obesity	5.54e-05	0.00116	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CLOCK—obesity	5.54e-05	0.00116	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOE—obesity	5.53e-05	0.00116	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SDC1—obesity	5.48e-05	0.00115	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CAV1—obesity	5.48e-05	0.00115	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOA1—obesity	5.46e-05	0.00115	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SULT2A1—obesity	5.4e-05	0.00113	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GLP1R—obesity	5.4e-05	0.00113	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKR1C3—obesity	5.39e-05	0.00113	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—DPYD—obesity	5.31e-05	0.00112	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADRB3—obesity	5.24e-05	0.0011	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GAL—obesity	5.12e-05	0.00108	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PRKAR2B—obesity	5.11e-05	0.00107	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—DCN—obesity	5.08e-05	0.00107	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—C5AR1—obesity	5.07e-05	0.00106	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—GOT2—obesity	5.01e-05	0.00105	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CG—obesity	4.99e-05	0.00105	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CPT1A—obesity	4.94e-05	0.00104	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FASN—obesity	4.91e-05	0.00103	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PARP1—obesity	4.89e-05	0.00103	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NAMPT—obesity	4.84e-05	0.00102	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PPARG—obesity	4.81e-05	0.00101	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LIPC—obesity	4.81e-05	0.00101	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GCK—obesity	4.81e-05	0.00101	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOC3—obesity	4.78e-05	0.001	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—POMC—obesity	4.75e-05	0.000997	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CETP—obesity	4.64e-05	0.000975	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCK—obesity	4.63e-05	0.000973	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRKG1—obesity	4.63e-05	0.000973	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOS1—obesity	4.59e-05	0.000965	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SDC1—obesity	4.59e-05	0.000964	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TCF7L2—obesity	4.55e-05	0.000955	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKR1C3—obesity	4.52e-05	0.000949	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RBP4—obesity	4.51e-05	0.000948	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GLP1R—obesity	4.51e-05	0.000948	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SLC2A4—obesity	4.47e-05	0.000939	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SCARB1—obesity	4.45e-05	0.000934	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HRH3—obesity	4.44e-05	0.000933	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCKAR—obesity	4.44e-05	0.000933	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CD—obesity	4.39e-05	0.000921	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ALB—obesity	4.33e-05	0.000909	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—GOT1—obesity	4.33e-05	0.000909	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SREBF1—obesity	4.32e-05	0.000907	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRKAR2B—obesity	4.28e-05	0.000898	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PRL—obesity	4.26e-05	0.000896	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GOT2—obesity	4.2e-05	0.000882	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3R1—obesity	4.14e-05	0.00087	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NCF2—obesity	4.13e-05	0.000867	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—FASN—obesity	4.11e-05	0.000863	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—BCHE—obesity	4.09e-05	0.00086	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FOXO3—obesity	4.05e-05	0.000852	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NPY—obesity	4.02e-05	0.000845	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOC3—obesity	4e-05	0.00084	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IAPP—obesity	4e-05	0.00084	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP2E1—obesity	3.95e-05	0.000829	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NQO1—obesity	3.9e-05	0.00082	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HTR1B—obesity	3.88e-05	0.000816	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CRH—obesity	3.88e-05	0.000816	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SDC1—obesity	3.84e-05	0.000806	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CB—obesity	3.82e-05	0.000803	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—obesity	3.79e-05	0.000796	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKR1C3—obesity	3.78e-05	0.000793	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GCG—obesity	3.74e-05	0.000786	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC2A4—obesity	3.74e-05	0.000786	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYCS—obesity	3.69e-05	0.000776	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NPS—obesity	3.68e-05	0.000773	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOB—obesity	3.67e-05	0.000771	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GGT1—obesity	3.62e-05	0.000761	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GOT1—obesity	3.62e-05	0.000761	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—DRD1—obesity	3.61e-05	0.000758	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HTR2C—obesity	3.61e-05	0.000758	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NCOA1—obesity	3.57e-05	0.00075	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—STK11—obesity	3.52e-05	0.000739	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP19A1—obesity	3.52e-05	0.000739	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NTRK2—obesity	3.51e-05	0.000738	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—LPL—obesity	3.51e-05	0.000737	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADRB1—obesity	3.5e-05	0.000734	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FOXO1—obesity	3.48e-05	0.000731	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PARP1—obesity	3.42e-05	0.000719	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GHRL—obesity	3.42e-05	0.000719	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—DRD4—obesity	3.39e-05	0.000713	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—COMT—obesity	3.27e-05	0.000687	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CNR1—obesity	3.24e-05	0.000681	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PRKCD—obesity	3.23e-05	0.000679	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GNB3—obesity	3.23e-05	0.000678	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPARGC1A—obesity	3.23e-05	0.000678	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HMOX1—obesity	3.21e-05	0.000674	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TCF7L2—obesity	3.18e-05	0.000669	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—DRD2—obesity	3.16e-05	0.000664	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MTHFR—obesity	3.16e-05	0.000663	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GNAS—obesity	3.14e-05	0.00066	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GCG—obesity	3.13e-05	0.000657	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTPN1—obesity	3.13e-05	0.000657	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOB—obesity	3.08e-05	0.000646	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IRS2—obesity	3e-05	0.000631	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRL—obesity	2.99e-05	0.000627	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STK11—obesity	2.94e-05	0.000618	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOE—obesity	2.94e-05	0.000617	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LPL—obesity	2.94e-05	0.000617	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CAV1—obesity	2.91e-05	0.000612	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PLG—obesity	2.91e-05	0.000611	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOA1—obesity	2.91e-05	0.00061	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GPX1—obesity	2.87e-05	0.000602	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FOXO3—obesity	2.84e-05	0.000596	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADRB2—obesity	2.83e-05	0.000595	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CD36—obesity	2.79e-05	0.000586	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SOCS1—obesity	2.79e-05	0.000586	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SOCS3—obesity	2.75e-05	0.000579	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—BAD—obesity	2.74e-05	0.000575	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GNB3—obesity	2.7e-05	0.000567	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF2—obesity	2.65e-05	0.000556	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MTHFR—obesity	2.64e-05	0.000555	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GNAS—obesity	2.63e-05	0.000552	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IRS1—obesity	2.62e-05	0.000551	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPARA—obesity	2.59e-05	0.000545	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOB—obesity	2.57e-05	0.00054	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AGT—obesity	2.51e-05	0.000528	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL5—obesity	2.51e-05	0.000528	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—INS—obesity	2.51e-05	0.000527	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOE—obesity	2.46e-05	0.000517	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LPL—obesity	2.46e-05	0.000516	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CAV1—obesity	2.44e-05	0.000512	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FOXO1—obesity	2.44e-05	0.000512	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RPS6KB1—obesity	2.43e-05	0.000511	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOA1—obesity	2.43e-05	0.000511	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT2—obesity	2.43e-05	0.00051	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CD—obesity	2.33e-05	0.00049	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.33e-05	0.000489	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SERPINE1—obesity	2.31e-05	0.000485	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRKCD—obesity	2.26e-05	0.000475	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TYK2—obesity	2.24e-05	0.000471	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—RHOA—obesity	2.22e-05	0.000467	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CG—obesity	2.22e-05	0.000467	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HTR2A—obesity	2.21e-05	0.000465	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—C3—obesity	2.21e-05	0.000464	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3R1—obesity	2.2e-05	0.000463	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOS3—obesity	2.2e-05	0.000463	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPARG—obesity	2.14e-05	0.00045	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—POMC—obesity	2.11e-05	0.000444	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IRS2—obesity	2.1e-05	0.000442	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—INS—obesity	2.1e-05	0.000442	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AGT—obesity	2.1e-05	0.000441	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LEP—obesity	2.06e-05	0.000432	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOE—obesity	2.06e-05	0.000432	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CAV1—obesity	2.04e-05	0.000428	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOA1—obesity	2.03e-05	0.000427	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MTOR—obesity	2.03e-05	0.000427	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CB—obesity	2.03e-05	0.000427	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTGS2—obesity	2.01e-05	0.000423	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ESR1—obesity	1.97e-05	0.000413	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CD—obesity	1.95e-05	0.00041	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRKCB—obesity	1.94e-05	0.000408	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—F2—obesity	1.94e-05	0.000408	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALB—obesity	1.93e-05	0.000405	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—BAD—obesity	1.92e-05	0.000403	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CG—obesity	1.86e-05	0.00039	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NOS3—obesity	1.84e-05	0.000387	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3R1—obesity	1.84e-05	0.000387	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IRS1—obesity	1.84e-05	0.000386	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—POMC—obesity	1.77e-05	0.000371	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—INS—obesity	1.76e-05	0.000369	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL2—obesity	1.73e-05	0.000363	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CB—obesity	1.7e-05	0.000358	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF1—obesity	1.7e-05	0.000357	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT2—obesity	1.7e-05	0.000357	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTGS2—obesity	1.69e-05	0.000354	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CD—obesity	1.63e-05	0.000343	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SERPINE1—obesity	1.62e-05	0.000339	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TYK2—obesity	1.57e-05	0.00033	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—STAT3—obesity	1.57e-05	0.00033	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RHOA—obesity	1.56e-05	0.000327	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3R1—obesity	1.54e-05	0.000324	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOS3—obesity	1.54e-05	0.000324	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MYC—obesity	1.46e-05	0.000307	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TGFB1—obesity	1.46e-05	0.000306	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CB—obesity	1.42e-05	0.000299	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MTOR—obesity	1.42e-05	0.000299	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CA—obesity	1.24e-05	0.00026	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP9—obesity	1.24e-05	0.00026	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAPK8—obesity	1.2e-05	0.000253	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STAT3—obesity	1.1e-05	0.000231	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6—obesity	1.1e-05	0.00023	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CA—obesity	1.04e-05	0.000218	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MYC—obesity	1.02e-05	0.000215	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TGFB1—obesity	1.02e-05	0.000214	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT1—obesity	1.01e-05	0.000213	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CA—obesity	8.68e-06	0.000182	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKT1—obesity	8.48e-06	0.000178	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6—obesity	7.68e-06	0.000161	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT1—obesity	7.09e-06	0.000149	CbGpPWpGaD
